Inmune Bio Inc (INMB)

SG&A Expense Growth

4.97%

Quarterly · Period ending:

INMB logo

INMB SG&A Expense Growth

Latest reported4.97%
INMB Quarterly SG&A Growth (QoQ) (0.00% → 4.97%)
High-resolution chart · PNG

INMB sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inmune Bio Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
4.9747%
-30.9698%
17.3507%
18.9525%
-2.7202%
16.1484%
-11.7309%
-19.6657%
20.2737%
-2.5833%
-7.1926%
11.9965%
-0.8162%
-0.0429%
-2.225%
7.5395%
-5.0172%
9.7412%
-15.507%
20.335%
1.407%
51.4328%
-44.5847%
103.9247%
-7.319%
-11.3441%
-23.4995%
14.2516%
-7.2968%
32.5616%
54.1713%
-84.9643%
114.6973%
1,615.1114%
-38.7945%
160.7221%
62.0608%
9.3946%
112.1921%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.